Investment & deals

  • Precisio Biotix secures additional funding for bacterial vaginosis treatment

    Precisio Biotix Therapeutics has secured Gates Foundation funding to advance an experimental bacterial vaginosis treatment through preclinical development. The US biotechnology company is developing a targeted antimicrobial designed to eliminate bacteria associated with bacterial vaginosis (BV), including antibiotic-resistant strains, while preserving beneficial vaginal bacteria. The funding will support further development of engineered lysins, proteins designed [...]

  • TFP Fertility Group acquires Manchester Fertility Group

    TFP Fertility Group has acquired Manchester Fertility Group, expanding its UK operations and presence in northwest England. Financial terms were not disclosed. TFP operates fertility and reproductive health clinics in the UK and Poland and has more than 35 years of clinical heritage. Manchester Fertility Group has provided fertility services since 1986 and operates a [...]

  • New accelerator targets women’s health research and investment gaps

    Upstart Impacts has opened applications for a women's health accelerator offering free commercialisation support to 10 early-stage biotech and medtech companies. The Philadelphia-based nonprofit aims to address gaps in medical research and expand opportunities for investment and product development among startups in Pennsylvania. The Women's Health Innovation Program will select participants in January, with its [...]

  • Femtech Tracker October 2026: The deals, data and developments shaping women’s health

    The October 2026 edition of Femtech Tracker provides a comprehensive snapshot of the women's health innovation sector over the past 30 days, highlighting the companies attracting investment, the technologies gaining momentum and the challenges facing the industry. This month's report covers major funding rounds, including Evvy's US$40 million Series B and Allara's US$30 million investment, [...]

  • Hormone tracking startup Unravel Health raises €2.96 million

    Unravel Health has raised €2.96m to develop a home hormone device designed to measure multiple hormones from a saliva sample in minutes. The London-based women’s health startup is developing the Micro Lab, a palm-sized device intended to allow women to monitor their hormone levels daily without laboratory visits. It is being designed to measure oestradiol, [...]

  • Collective X Health launches with US$3.2 million pre-seed round

    Collective X Health has launched with US$3.2m in pre-seed funding to expand its women’s health data platform and support further research. The company licenses research-backed insights on female physiology to wearable technology companies, digital health platforms and performance brands. The funding will support research across different life stages and conditions, expand the platform’s capabilities and [...]

  • Allara raises US$30m to improve access to hormonal and reproductive healthcare

    Allara has raised US$30m to develop AI tools, expand access to women’s healthcare and fund research, bringing its total funding to US$75m. The US virtual healthcare company provides integrated care for hormonal, metabolic and reproductive conditions. In a survey of more than 1,600 women joining Allara, 58 per cent had already consulted at least two [...]

  • UNICEF and Sweden offer up to US$100,000 in funding for femtech startups

    Femtech companies developing technology to improve the health and wellbeing of girls and women could secure up to US$100,000 in funding, a year of expert technical support and access to UNICEF’s global network through a new initiative backed by Sweden and UNICEF. Applicants to the UNICEF FemTech Ventures programme must be registered in a UNICEF [...]

  • EIB to invest €250m in Bangladesh to expand women’s healthcare

    Bangladesh and the European Investment Bank (EIB) plan €250m to expand women’s healthcare for around 47 million women and adolescent girls from 2027 to 2031. The programme, called the Women’s Health Initiative, aims to improve maternal and newborn healthcare, cervical and breast cancer treatment and emergency obstetric services. It will also strengthen primary healthcare, district [...]

  • Gloriah raises £600k for UK growth and US expansion

    Gloriah has raised £600,000 in an oversubscribed funding round to expand its UK retail presence and prepare for growth in the US. The Scotland-based female health company focuses on supporting women through hormonal changes and intimate health concerns. Founded in 2021 by Jessica Rose Watson and Isla Wynne Thomas, Gloriah was created in response to [...]